1. O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA. Dyspnea in COPD: New Mechanistic Insights and Management Implications. Adv Ther. 2020;37(1):41–60.
2. O’Donnell DE, Neder JA. The enigma of dyspnoea in COPD: A physiological perspective. Respirology. 2020;25(2):134–136.
3. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5):4S–42S.
4. Vitacca M, Paneroni M. Rehabilitation of patients with coexisting COPD and heart failure. COPD J Chronic Obstr Pulm Dis. 2018;15(3):231–237.
5. Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing. 2002;31(2):137–140.
6. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.
7. Matsuda T, Taniguchi H, Ando M, et al. COPD assessment test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study. Respirology. 2017;22(4):721–727.
8. Nishiyama O, Taniguchi H, Kondoh Y, et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. 2010;36(5):1067–1072.
9. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 Report); 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD- 2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed October 5th, 2020.
10. Vaes AW, Delbressine JML, Mesquita R, et al. Impact of pulmonary rehabilitation on activities of daily living in patients with chronic obstructive pulmonary disease. J Appl Physiol. 2018;126(3):607–615.
11. Kozu R, Senjyu H, Jenkins SC, Mukae H, Sakamoto N, Kohno S. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration. 2011;81(3):196–205.
12. Yohannes AM, Roomi J, Waters K, Connolly MJ. A comparison of the Barthel index and Nottingham extended activities of daily living scale in the assessment of disability in chronic airflow limitation in old age. Age Ageing. 1998;27(3):369–374.
13. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol. 1989;42(8):703–709.
14. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: The London chest activity of daily living scale (LCADL). Respir Med. 2000;94(6):589–596.
15. Lareau SC, Meek PM, Roos PJ, Calif LL, Ariz T. Development and testing of the modified version of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ-M). Heart Lung. 1998;27(3):159–168.
16. Vitacca M, Paneroni M, Baiardi P, et al. Development of a Barthel Index based on dyspnea for patients with respiratory diseases. Int J COPD. 2016;11(1):1199–1206.
17. Janaudis-Ferreira T, Beauchamp MK, Robles PG, Goldstein RS, Brooks D. Measurement of activities of daily living in patients with COPD: A systematic review. Chest. 2014;145(2):253– 271.
18. Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94–104.
19. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: A practical guide. Cambridge, England: Cambridge University Press; 2011.
20. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338.
21. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
22. COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) user manual. Version 1.0 dated February 2018. Available from: https://www.cosmin.nl/wp-content/uploads/COSMIN-syst-review-for-PROMs- manual_version-1_feb-2018-1.pdf. Accessed October 5th, 2020. Accessed May 5th, 2021
23. Guyatt GH, King DR, Feeny DH, et al. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol. 1999;52(3):187- 192
24. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60(1):34-42
25. de Vet HC, Terwee CB, Knol DL, et al. When to use agreement versus reliability measures. J Clin Epidemiol. 2006;59(10):1033-9
26. Kojima S, Ando M, Okazawa H, Sakakibara S, Hashimoto S, Nakajima S. [Development of a Japanese version of the modified questionnaire on the pulmonary functional status and dyspnea]. Nihon Kokyuki Gakkai Zasshi [The Journal of the Japanese Respiratory Society]; 2004;42(6):486–490. [in Japanese].
27. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284–290.
28. Bland JM, Altman DG. Statistics notes: Cronbach’s alpha. BMJ. 1997;314(7080):572.